Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gehrmann

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Biochemistry|February 29, 2000
Enzyme immunoassay for the measurement of human tenascin-C on the Bayer Immuno 1 analyzerT Ropers, W Kroll, M Becka, et al.
Scandinavian Journal of Rheumatology|March 9, 2007
Heat shock protein 70 membrane expression on fibroblast-like synovial cells derived from synovial tissue of patients with rheumatoid and juvenile idiopathic arthritisT T H Nguyen, M Gehrmann, D Zlacka, et al.
Cell Death and Differentiation|December 14, 2004
Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cellsM Gehrmann, J Marienhagen, H Eichholtz-Wirth, et al.
European Journal of Biochemistry|March 27, 1999
Homologous plasminogen N-terminal and plasminogen-related gene A and B peptides. Characterization of cDNAs and recombinant fusion proteinsV O Lewis, M Gehrmann, L Weissbach, et al.
Breast Cancer Research and Treatment|March 15, 2008
Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancerA Rody, T Karn, E Ruckhäberle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2008
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trialM Schmidt, A Victor, D Bratzel, et al.
British Journal of Cancer|January 11, 2007
Role of the progesterone receptor for paclitaxel resistance in primary breast cancerM Schmidt, E Bremer, D Hasenclever, et al.
British Journal of Cancer|October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancerS Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Biochemistry|February 29, 2000
Enzyme immunoassay for the measurement of human tenascin-C on the Bayer Immuno 1 analyzerT Ropers, W Kroll, M Becka, et al.
Scandinavian Journal of Rheumatology|March 9, 2007
Heat shock protein 70 membrane expression on fibroblast-like synovial cells derived from synovial tissue of patients with rheumatoid and juvenile idiopathic arthritisT T H Nguyen, M Gehrmann, D Zlacka, et al.
Cell Death and Differentiation|December 14, 2004
Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cellsM Gehrmann, J Marienhagen, H Eichholtz-Wirth, et al.
European Journal of Biochemistry|March 27, 1999
Homologous plasminogen N-terminal and plasminogen-related gene A and B peptides. Characterization of cDNAs and recombinant fusion proteinsV O Lewis, M Gehrmann, L Weissbach, et al.
Breast Cancer Research and Treatment|March 15, 2008
Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancerA Rody, T Karn, E Ruckhäberle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2008
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trialM Schmidt, A Victor, D Bratzel, et al.
British Journal of Cancer|January 11, 2007
Role of the progesterone receptor for paclitaxel resistance in primary breast cancerM Schmidt, E Bremer, D Hasenclever, et al.
British Journal of Cancer|October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancerS Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
Pageof 3